文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

导致胃轻瘫患者生活质量受损的因素。

Factors that contribute to the impairment of quality of life in gastroparesis.

机构信息

Temple University. Philadelphia, PA, USA.

Johns Hopkins University, Baltimore, MD, USA.

出版信息

Neurogastroenterol Motil. 2021 Aug;33(8):e14087. doi: 10.1111/nmo.14087. Epub 2021 Jan 25.


DOI:10.1111/nmo.14087
PMID:33493377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8310540/
Abstract

BACKGROUND: Understanding factors that impair quality of life (QOL) in gastroparesis is important for clinical management. AIMS: (a) Determine QOL in patients with gastroparesis; (b) Determine factors that impair QOL. METHODS: Gastroparetic patientsAQ6 underwent history and questionnaires assessing symptoms (PAGI-SYM and Rome III), QOL (SF-36v2 and PAGI-QOL), depression (Beck Depression Inventory [BDI]), and anxiety (State Trait Anxiety InventoryAQ7). KEY RESULTS: 715 gastroparesis patients (256 diabetic (DG), 459 idiopathic (IG)) were evaluated. SF-36 physical component (PC) score averaged 33.3 ± 10.5; 41% had impaired score <30. SF-36 PC scores were similar between diabetic and idiopathic gastroparesis. Impaired SF-36 PC associated with increased nausea/vomiting and upper abdominal pain subscores, acute onset of symptoms, higher number of comorbidities, use of narcotic pain medications, and irritable bowel syndrome (IBS). SF-36 mental component (MC) score averaged 38.9 ± 13.0; 26% had impaired score <30. Poor SF-36 MC associated with diabetic etiology, higher Beck depression inventory, and state anxiety scores. PAGI-QOL score averaged 2.6 ± 1.1; 50% had a score of <2.6. Low PAGI-QOL associated with higher fullness, bloating, and upper abdominal pain subscores, more depression and Trait anxiety, smoking cigarettes, need for nutritional support, progressively worsening symptoms and periodic exacerbations. CONCLUSIONS & INFERENCES: Multiple measures show poor QOL present in gastroparesis. Several areas impacted on reduced QOL: (a) Symptoms of nausea, vomiting, and abdominal pain, as well as IBS; (b) Etiology and acute onset and progressively worsening symptoms; (c) Comorbidities and psychological factors such as anxiety and depression; (d) Patient-related factors such as smoking. Targeting the modifiable factors may improve patient outcomes in gastroparesis.

摘要

背景:了解影响胃轻瘫患者生活质量(QOL)的因素对于临床管理很重要。

目的:(a)确定胃轻瘫患者的 QOL;(b)确定影响 QOL 的因素。

方法:胃轻瘫患者接受了病史和问卷评估,包括症状(PAGI-SYM 和 Rome III)、QOL(SF-36v2 和 PAGI-QOL)、抑郁(贝克抑郁量表[BDI])和焦虑(状态特质焦虑量表 AQ7)。

主要结果:共评估了 715 例胃轻瘫患者(256 例糖尿病性[DG],459 例特发性[IG])。SF-36 生理成分(PC)评分平均为 33.3±10.5;41%的患者得分<30,表明 PC 评分受损。糖尿病性和特发性胃轻瘫患者的 SF-36 PC 评分相似。PC 评分受损与恶心/呕吐和上腹痛亚量表评分增加、症状急性发作、合并症数量增加、使用麻醉性止痛药和肠易激综合征(IBS)相关。SF-36 心理成分(MC)评分平均为 38.9±13.0;26%的患者得分<30,表明 MC 评分受损。SF-36 MC 评分差与糖尿病病因、更高的贝克抑郁量表和状态焦虑评分相关。PAGI-QOL 评分平均为 2.6±1.1;50%的患者评分<2.6,表明 QOL 较低。PAGI-QOL 评分低与饱胀感、腹胀和上腹痛亚量表评分增加、更多的抑郁和特质焦虑、吸烟、需要营养支持、症状逐渐恶化和周期性加重相关。

结论:多项指标表明胃轻瘫患者的 QOL 较差。多个方面影响 QOL 降低:(a)恶心、呕吐和腹痛以及 IBS 等症状;(b)病因、急性发作和逐渐恶化的症状;(c)合并症和焦虑、抑郁等心理因素;(d)患者相关因素,如吸烟。针对可改变的因素可能会改善胃轻瘫患者的预后。

相似文献

[1]
Factors that contribute to the impairment of quality of life in gastroparesis.

Neurogastroenterol Motil. 2021-8

[2]
Abdominal Pain in Patients with Gastroparesis: Associations with Gastroparesis Symptoms, Etiology of Gastroparesis, Gastric Emptying, Somatization, and Quality of Life.

Dig Dis Sci. 2019-3-9

[3]
Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting.

Neurogastroenterol Motil. 2013-2-17

[4]
Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing.

Neurogastroenterol Motil. 2017-4

[5]
Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis.

Neurogastroenterol Motil. 2016-12

[6]
Nausea and vomiting in diabetic and idiopathic gastroparesis.

Neurogastroenterol Motil. 2011-11-27

[7]
Symptom variability throughout the day in patients with gastroparesis.

Neurogastroenterol Motil. 2020-2

[8]
Ethnic, Racial, and Sex Differences in Etiology, Symptoms, Treatment, and Symptom Outcomes of Patients With Gastroparesis.

Clin Gastroenterol Hepatol. 2018-11-4

[9]
Rome IV Diagnostic Questionnaire Complements Patient Assessment of Gastrointestinal Symptoms for Patients with Gastroparesis Symptoms.

Dig Dis Sci. 2018-5-28

[10]
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders.

Qual Life Res. 2004-12

引用本文的文献

[1]
Gastric peroral endoscopic myotomy improves chronic diarrhea in patients with refractory gastroparesis.

Ann Gastroenterol. 2025

[2]
Whole Gut Motility Patterns in Patients with Chronic Nausea and Vomiting.

J Clin Med. 2024-11-25

[3]
A bibliometric analysis of diabetic gastroparesis from 1979 to 2024.

Front Med (Lausanne). 2024-10-10

[4]
Scoping review: the social and emotional impacts of gastroparesis.

Transl Gastroenterol Hepatol. 2024-7-10

[5]
Diabetic Gastroparesis and its Emerging Therapeutic Options: A Narrative Review of the Literature.

Cureus. 2023-9-7

[6]
Prevalence of gastroparesis in diabetic patients: a systematic review and meta-analysis.

Sci Rep. 2023-8-28

[7]
Effectiveness and safety of traditional Chinese medicine decoction for diabetic gastroparesis: A network meta-analysis.

World J Diabetes. 2023-3-15

[8]
Characteristics and outcomes of patients with gastroparesis using enteral and/or exclusive parenteral nutrition.

JPEN J Parenter Enteral Nutr. 2023-5

[9]
Worldwide prevalence and burden of gastroparesis-like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.

United European Gastroenterol J. 2022-10

[10]
Progress in Gastroparesis - A Narrative Review of the Work of the Gastroparesis Clinical Research Consortium.

Clin Gastroenterol Hepatol. 2022-12

本文引用的文献

[1]
The Burdens, Concerns, and Quality of Life of Patients with Gastroparesis.

Dig Dis Sci. 2017-4

[2]
Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis.

Neurogastroenterol Motil. 2016-12

[3]
The relationship among gastroparetic symptoms, quality of life, and gastric emptying in patients referred for gastric emptying testing.

Neurogastroenterol Motil. 2016-2

[4]
Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis.

Gastroenterology. 2015-8-21

[5]
Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting.

Neurogastroenterol Motil. 2013-2-17

[6]
The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood.

Aliment Pharmacol Ther. 2012-11-5

[7]
Nausea and vomiting in diabetic and idiopathic gastroparesis.

Neurogastroenterol Motil. 2011-11-27

[8]
Similarities and differences between diabetic and idiopathic gastroparesis.

Clin Gastroenterol Hepatol. 2011-8-24

[9]
Bloating in gastroparesis: severity, impact, and associated factors.

Am J Gastroenterol. 2011-4-12

[10]
Characteristics of nausea and its effects on quality of life in diabetic and idiopathic gastroparesis.

J Clin Gastroenterol. 2011-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索